Skip to main content
Back
Watch Compare

STANDARD BIOTOOLS INC.

Data quality: 100%
LAB
Nasdaq Manufacturing Measuring & Analyzing Instruments
$0.91
▼ $0.03 (-3.00%)
Mkt Cap: 354.46 M
Price
$0.91
Mkt Cap
354.46 M
Day Range
$0.89 — $0.95
52-Week Range
$0.87 — $1.72
Volume
961,056
Open $0.95
50D / 200D Avg
$1.11
18.43% below
50D / 200D Avg
$1.28
28.97% below

Quick Summary

Key Takeaways

Revenue declined -10.09% annually over 5 years
Negative free cash flow of -82.65 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 40.99%
Capital efficient — spends only 9.73% of revenue on capex

Growth

Revenue Growth (5Y)
-10.09%
Below sector avg (9.35%)
Revenue (1Y)-51.08%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-18.17%
Above sector avg (-51.02%)
ROIC-19.56%
Net Margin-87.77%
Op. Margin-129.20%

Safety

Debt / Equity
N/A
Current Ratio4.38
Interest CoverageN/A

Valuation

PE (TTM)
-4.73
Below sector avg (-1.98)
P/B Ratio0.89
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -4.7 -2.0
P/B 0.9 5.1
ROE % -18.2 -51.0
Net Margin % -87.8 -150.2
Rev Growth 5Y % -10.1 9.3
D/E — 0.3

ETFs Holding This Stock

IWV logo IWV iShares Russell 3000 ETF
0.00% weight
EBI logo EBI Longview Advantage ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -51.08% Revenue Growth (3Y) -10.42%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -10.09% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 85.33 M Net Income (TTM) -74.90 M
ROE -18.17% ROA -13.66%
Gross Margin 49.86% Operating Margin -129.20%
Net Margin -87.77% Free Cash Flow (TTM) -82.65 M
ROIC -19.56% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.38
Interest Coverage N/A Asset Turnover 0.16
Working Capital 364.47 M Tangible Book Value 399.66 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.73 Forward P/E N/A
P/B Ratio 0.89 P/S Ratio 4.15
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -23.32%
Market Cap 354.46 M Enterprise Value 225.04 M
Per Share
EPS (Diluted TTM) -0.20 Revenue / Share 0.22
FCF / Share -0.21 OCF / Share -0.19
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 9.73% FCF Conversion 110.35%
SBC-Adj. FCF -124.86 M Growth Momentum -40.99

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 85.33 M 174.43 M 106.34 M 97.95 M 130.58 M
Net Income -74.90 M -138.89 M -74.66 M -190.10 M -59.24 M
EPS (Diluted) -0.20 -0.52 -0.94 -2.43 -0.78
Gross Profit 42.54 M 84.26 M 50.45 M — —
Operating Income -110.25 M -175.24 M -76.60 M -116.21 M -67.46 M
EBITDA — — — — —
R&D Expenses 25.99 M 62.41 M 25.95 M 38.50 M 37.94 M
SG&A Expenses 109.86 M 156.61 M 87.54 M 114.76 M 98.89 M
D&A — 12.30 M 12.67 M 6.22 M —
Interest Expense — — 4.57 M 4.33 M 3.82 M
Income Tax -37.88 M 573,000.0 452,000.0 -2.83 M -4.42 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 567.75 M 612.34 M 323.07 M 390.31 M 275.21 M
Total Liabilities 143.46 M 140.62 M 159.87 M 160.52 M 180.62 M
Shareholders' Equity 424.29 M 471.72 M -148.05 M -81.47 M 94.60 M
Total Debt — 299,000.0 63.51 M — —
Cash & Equivalents 120.86 M 166.73 M 51.70 M 81.31 M 28.45 M
Current Assets 454.26 M 375.88 M 158.22 M 208.82 M 72.07 M
Current Liabilities 108.31 M 65.89 M 109.33 M 43.44 M 49.57 M